Putting knowledge into practice: Does information on adverse drug interactions influence people's dosing behaviour?

Area of Science:

• Pharmacology and Behavioral Science
• Patient Safety Research
• Risk Perception Studies

Background:

• Adverse drug events from drug-drug interactions are a significant cause of patient harm.
• Patient comprehension of synergistic drug risks is vital for preventing harm.
• Existing research lacks clarity on whether synergistic interactions influence risk perception and dosing decisions.

Purpose of the Study:

• To investigate if information about synergistic drug-drug interaction risks increases perceived risk and influences dosing behavior.
• To examine the impact of additive versus synergistic risk information on participant behavior.
• To explore how risk size and participant role (patient/doctor) affect responses to drug interaction information.

Main Methods:

• Experimental design with two studies.
• Participants received scenarios with varying information on drug combination risks (none, additive, synergistic).
• Experiment 2 manipulated risk size (small/large) and participant role (patient/doctor).

Main Results:

• Information about synergistic drug-drug interaction risks led to increased perceived risk and negative affect.
• Despite heightened risk perception, participants did not alter their drug dosing behavior in either experiment.
• Dosing behavior remained consistent regardless of interaction magnitude (large/small) or type (synergistic/additive).

Conclusions:

• Individuals may face challenges translating knowledge of drug-drug interaction risks into practical decision-making.
• Accurate risk perceptions of drug side effects do not automatically translate into behaviors that prevent adverse events.
• Further research is needed to bridge the gap between risk awareness and safe medication practices.